Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Clinical trial NCT02828202 · RECRUITING

Trial details

NCT number: NCT02828202
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Study type: OBSERVATIONAL

Malignant Melanoma

Start date: 2013-02-01
Primary completion: 2026-03-01
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.